Pharma major Lupin on Saturday said that its Pithampur facilities has seen the successful completion of the inspection carried out by the UK Medicines and Healthcare products Regulatory Agency (UK MHRA)
Pharma major Lupin on Saturday said that its Pithampur facilities has seen the successful completion of the inspection carried out by the UK Medicines and Healthcare products Regulatory Agency (UK MHRA).
“We are proud that our Pithampur site has been successfully inspected by the MHRA again, highlighting our unwavering commitment to quality and compliance. With the combination of oral solid, inhalation, dermatology, high potent and oral contraceptive products, this is an important facility and maintaining the highest standards of quality and compliance is a must,” said Nilesh Gupta, Managing Director, Lupin.
Tags assigned to this article:
